$0.074
-0.027 (-37.11%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
BTAI-Prognose durch Analyse ähnlicher Charts
Alphio's BTAI stock price prediction model matches the current BioXcel Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.07 (-0.11%). The 1-week path is $0.07 (+0.62%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich BioXcel Therapeutics Inc-Aktien kaufen?
BioXcel Therapeutics Inc is not a good buy right now due to its significant financial distress and recent bankruptcy filing. The current price is $0.0739, which reflects a staggering 95.65% decline year-to-date. Additionally, the company has reported a gross margin of only 87.91% in the most recent quarter, indicating severe operational challenges. The primary risk is its recent bankruptcy filing, which raises concerns about the company's ability to continue operations and meet obligations.
BTAI schloss am Friday bei $0.07, nachdem der Kurs -37.11% fallen
BioXcel Therapeutics Inc (BTAI) last closed at $0.0739, losing -37.11%. These facts feed the 1-day and 1-week BTAI price prediction above.
Analystenkonsens
BioXcel Therapeutics Inc (BTAI): 4 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von BioXcel Therapeutics Inc (BTAI) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf BTAI am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für BTAI
Historically the probability of a positive November return for BTAI is 0.00%. January offers the highest probability of a positive month at 39.34%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für BTAI
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $0.92 | $0.94 | $0.95 | +1166.93% |
| Dec 2026 | $0.70 | $0.86 | $0.94 | +1064.31% |
Für 2026 wird für BioXcel Therapeutics Inc (BTAI) eine Spanne von $0.70 bis $0.95 projiziert.
Monatsprognose 2026 für BioXcel Therapeutics Inc
Im Nov 2026 wird für BioXcel Therapeutics Inc ein Durchschnitt von $0.94 erwartet, mit einem Tief von $0.92 und einem Hoch von $0.95.
Im Dec 2026 wird für BioXcel Therapeutics Inc ein Durchschnitt von $0.86 erwartet, mit einem Tief von $0.70 und einem Hoch von $0.94.
Ähnliche Artikel
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
- Bitcoin Bear Market 2026: Why BTC Fell Below $70K and How Investors Can Manage Crypto RiskBitcoin is about 45% below its $126K peak as Fed hikes, 5% yields and ETF outflows bite. See how the 2026 bear market compares and how to manage crypto risk.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.